ZEOX (Zeo ScientifiX) Tariff Resilience Score: 5/10 (As of Jul. 05, 2026)


ZEOX Zeo ScientifiX Inc ZEOX
56 GF Score
Price $1.90
GF Value $2.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Zeo ScientifiX Tariff Resilience Score?

Zeo ScientifiX ZEOX +7.34% 56 Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus rates ZEOX with a GF Score™ of 56/100 and a GF Value™ of $2.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,369 Biotechnology companies, Zeo ScientifiX ranks better than 62.38% on this metric.

Zeo ScientifiX has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Zeo ScientifiX has Zeo ScientifiX relies on international suppliers for key components, exposing it to tariff risks. However, its niche market and potential for alternative sourcing offer some mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Zeo ScientifiX might have Average Resilient.

Zeo ScientifiX  (OTCPK:ZEOX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Zeo ScientifiX Tariff Resilience Score Related Terms

ZEOX vs JUNS, HOOK, LEXX: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Zeo ScientifiX's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zeo ScientifiX Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Zeo ScientifiX's Tariff Resilience Score falls into.


ZEOX
56GF Score
Zeo ScientifiX Inc ZEOX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Zeo ScientifiX (ZEOX) has a Tariff Resilience Score of 5 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Zeo ScientifiX ranks #515 out of 1369 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Zeo ScientifiX's Tariff Resilience Score too high?
Zeo ScientifiX's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Zeo ScientifiX's value of 5 is 25% above this industry median. Based on the distribution chart, Zeo ScientifiX ranks #515 out of 1369 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zeo ScientifiX has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Tariff Resilience Score compare to JUNS and HOOK?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #515 out of 1369 companies for Tariff Resilience Score. This puts Zeo ScientifiX in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Zeo ScientifiX's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zeo ScientifiX's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.67, compared to a current price of $1.90 — trading 28.8% below its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Zeo ScientifiX's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeo ScientifiX (ZEOX) Overvalued in 2026?

Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued. The current stock price of $1.90 is trading 28.8% below its estimated GF Value™ of $2.67. GuruFocus considers Zeo ScientifiX to be Modestly Undervalued.

Key valuation signals for ZEOX:

  • Tariff Resilience Score: 5
  • GF Value™: $2.67 vs. price of $1.90 (28.8% below fair value)
  • GF Score™: 56/100 with 4 warning signs
  • Industry Position: 25% above the Biotechnology median (#515 of 1369)

No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeo ScientifiX Business Description

Address 3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
56GF Score

Get the complete analysis for ZEOX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price
$2.67
GF Value